Osaic Holdings
MXCT icon

Osaic Holdings’s MaxCyte MXCT Stock Holding History

Osaic Holdings’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$329 Sell
470
-20
-4% -$19 ﹤0.01% 7497
2025
Q4 		$759 Hold
490
– – ﹤0.01% 7343
2025
Q3 		$735 Sell
490
-95
-16% -$165 ﹤0.01% 7452
2025
Q2 		$1.27K Sell
585
-805
-58% -$1.95K ﹤0.01% 7080
2025
Q1 		$3.79K Buy
+1,390
New +$5.48K ﹤0.01% 6320
2024
Q3 		– Sell
-125
Closed -$490 – 7501
2024
Q2 		$490 Sell
125
-143
-53% -$615 ﹤0.01% 6989
2024
Q1 		$1.12K Sell
268
-4,227
-94% -$19.8K ﹤0.01% 6652
2023
Q4 		$21.1K Buy
4,495
+699
+18% +$2.72K ﹤0.01% 5472
2023
Q3 		$11.8K Buy
3,796
+1,347
+55% +$5.42K ﹤0.01% 5830
2023
Q2 		$11.2K Buy
2,449
+1,349
+123% +$6.2K ﹤0.01% 5899
2023
Q1 		$5.45K Hold
1,100
– – ﹤0.01% 6287
2022
Q4 		$6K Hold
1,100
– – ﹤0.01% 6210
2022
Q3 		$8K Hold
1,100
– – ﹤0.01% 6135
2022
Q2 		$5K Hold
1,100
– – ﹤0.01% 6478
2022
Q1 		$8K Buy
1,100
+400
+57% +$2.73K ﹤0.01% 6275
2021
Q4 		$7K Buy
+700
New +$7.52K ﹤0.01% 6474

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Osaic Holdings's MXCT Position: Q1 2026 in Review

Osaic Holdings reduced its MaxCyte (MXCT) stake by 4.1% in Q1 2026, selling an estimated $19 and leaving 470 shares worth $329. The position accounts for ﹤0.01% of the portfolio, ranked #7497.

Osaic Holdings first reported a position in MXCT in Q4 2021 and has held it in 16 quarters since. The position peaked at $21.1K in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Osaic Holdings held 470 shares of MaxCyte worth $329 as of Q1 2026.
  • Osaic Holdings sold 20 MaxCyte shares in Q1 2026, an estimated $19.
  • MaxCyte made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7497 holding.
  • Osaic Holdings first reported a position in MaxCyte in Q4 2021 and has held it in 16 quarters since.
  • Osaic Holdings's MaxCyte position peaked at $21.1K in Q4 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.